2017 - IXA
This page contains exclusive content for the member of the following sections: TTS, IXA. Log in to view.
yperimmunized/iABO Pre-Meeting Symposium - Hyperimmunized Patients
9.8 - New Agents for the Prevention and Treatment of AMR
Presenter: Stanley, Jordan, West Hollywood, United States
Authors:
New Agents for the Prevention and Treatment of AMR
Stanley Jordan, Director, Nephrology & Transplant Immunology, Medical Director, Kidney Transplant Program, Kidney Transplant, Cedars Sinai , West Hollywood, CA, United States
Important Disclaimer
By viewing the material on this site you understand and accept that:
- The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
- The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
- The material is solely for educational purposes for qualified health care professionals.
- The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
- The information cannot be used as a substitute for professional care.
- The information does not represent a standard of care.
- No physician-patient relationship is being established.
Social
Address
International Xenotransplantation Association
C/O The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada